Skip to main content
. 2020 Nov 10;12(11):3316. doi: 10.3390/cancers12113316

Figure 1.

Figure 1

Cardiovascular adverse outcomes in patients with cancer during Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection are exacerbated by four interrelated risk factors: cancer itself, which causes immunosuppressive effects; cardiotoxic, pro-fibrotic, and pro-inflammatory anticancer therapies; history of cardiovascular diseases (hypertension, coronary heart disease, or diabetes); direct cardiac effects of SARS-CoV-2 infection.